Literature DB >> 25842288

PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity.

Anne-Laure Mathieu1, Estelle Verronese2, Gillian I Rice3, Fanny Fouyssac4, Yves Bertrand5, Capucine Picard6, Marie Chansel7, Jolan E Walter8, Luigi D Notarangelo9, Manish J Butte10, Kari Christine Nadeau10, Krisztian Csomos8, David J Chen11, Karin Chen12, Ana Delgado2, Chantal Rigal2, Christine Bardin2, Catharina Schuetz13, Despina Moshous7, Héloïse Reumaux14, François Plenat15, Alice Phan16, Marie-Thérèse Zabot17, Brigitte Balme18, Sébastien Viel19, Jacques Bienvenu19, Pierre Cochat16, Mirjam van der Burg20, Christophe Caux2, E Helen Kemp21, Isabelle Rouvet17, Christophe Malcus22, Jean-Francois Méritet23, Annick Lim24, Yanick J Crow3, Nicole Fabien25, Christine Ménétrier-Caux2, Jean-Pierre De Villartay7, Thierry Walzer1, Alexandre Belot26.   

Abstract

BACKGROUND: PRKDC encodes for DNA-dependent protein kinase catalytic subunit (DNA-PKcs), a kinase that forms part of a complex (DNA-dependent protein kinase [DNA-PK]) crucial for DNA double-strand break repair and V(D)J recombination. In mice DNA-PK also interacts with the transcription factor autoimmune regulator (AIRE) to promote central T-cell tolerance.
OBJECTIVE: We sought to understand the causes of an inflammatory disease with granuloma and autoimmunity associated with decreasing T- and B-cell counts over time that had been diagnosed in 2 unrelated patients.
METHODS: Genetic, molecular, and functional analyses were performed to characterize an inflammatory disease evocative of a combined immunodeficiency.
RESULTS: We identified PRKDC mutations in both patients. These patients exhibited a defect in DNA double-strand break repair and V(D)J recombination. Whole-blood mRNA analysis revealed a strong interferon signature. On activation, memory T cells displayed a skewed cytokine response typical of TH2 and TH1 but not TH17. Moreover, mutated DNA-PKcs did not promote AIRE-dependent transcription of peripheral tissue antigens in vitro. The latter defect correlated in vivo with production of anti-calcium-sensing receptor autoantibodies, which are typically found in AIRE-deficient patients. In addition, 9 months after bone marrow transplantation, patient 1 had Hashimoto thyroiditis, suggesting that organ-specific autoimmunity might be linked to nonhematopoietic cells, such as AIRE-expressing thymic epithelial cells.
CONCLUSION: Deficiency of DNA-PKcs, a key AIRE partner, can present as an inflammatory disease with organ-specific autoimmunity, suggesting a role for DNA-PKcs in regulating autoimmune responses and maintaining AIRE-dependent tolerance in human subjects.
Copyright © 2015 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoimmune regulator; DNA-dependent protein kinase catalytic subunit; PRKDC; VDJ recombination; autoimmunity; recombination-activating gene; severe combined immunodeficiency; tolerance

Mesh:

Substances:

Year:  2015        PMID: 25842288      PMCID: PMC4487867          DOI: 10.1016/j.jaci.2015.01.040

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  42 in total

1.  Primary humoral immunodeficiency (late-onset common variable immunodeficiency) with antinuclear antibodies and selective immunoglobulin deficiency.

Authors:  E Andrès; F X Limbach; J E Kurtz; V Kurtz-Illig; T Schaeverbeke; F Pflumio; J L Kuntz; J Sibilia
Journal:  Am J Med       Date:  2001-10-15       Impact factor: 4.965

2.  Aire's partners in the molecular control of immunological tolerance.

Authors:  Jakub Abramson; Matthieu Giraud; Christophe Benoist; Diane Mathis
Journal:  Cell       Date:  2010-01-08       Impact factor: 41.582

3.  Omenn syndrome is associated with mutations in DNA ligase IV.

Authors:  Eyal Grunebaum; Andrea Bates; Chaim M Roifman
Journal:  J Allergy Clin Immunol       Date:  2008-10-09       Impact factor: 10.793

4.  CVID-associated TACI mutations affect autoreactive B cell selection and activation.

Authors:  Neil Romberg; Nicolas Chamberlain; David Saadoun; Maurizio Gentile; Tuure Kinnunen; Yen Shing Ng; Manmeet Virdee; Laurence Menard; Tineke Cantaert; Henner Morbach; Rima Rachid; Natalia Martinez-Pomar; Nuria Matamoros; Raif Geha; Bodo Grimbacher; Andrea Cerutti; Charlotte Cunningham-Rundles; Eric Meffre
Journal:  J Clin Invest       Date:  2013-09-24       Impact factor: 14.808

Review 5.  Clinical and immunological manifestations of patients with atypical severe combined immunodeficiency.

Authors:  Kerstin Felgentreff; Ruy Perez-Becker; Carsten Speckmann; Klaus Schwarz; Krzysztof Kalwak; Gasper Markelj; Tadej Avcin; Waseem Qasim; E G Davies; Tim Niehues; Stephan Ehl
Journal:  Clin Immunol       Date:  2011-05-30       Impact factor: 3.969

6.  Prevalence and pattern of antinuclear autoantibodies in 347 patients with non-Hodgkin's lymphoma.

Authors:  Stephanie Guyomard; Gilles Salles; Marie Coudurier; Hugues Rousset; Bertrand Coiffier; Jacques Bienvenu; Nicole Fabien
Journal:  Br J Haematol       Date:  2003-10       Impact factor: 6.998

7.  Myeloid cells, BAFF, and IFN-gamma establish an inflammatory loop that exacerbates autoimmunity in Lyn-deficient mice.

Authors:  Patrizia Scapini; Yongmei Hu; Ching-Liang Chu; Thi-Sau Migone; Anthony L Defranco; Marco A Cassatella; Clifford A Lowell
Journal:  J Exp Med       Date:  2010-07-12       Impact factor: 14.307

8.  Expansion of immunoglobulin-secreting cells and defects in B cell tolerance in Rag-dependent immunodeficiency.

Authors:  Jolan E Walter; Francesca Rucci; Laura Patrizi; Mike Recher; Stephan Regenass; Tiziana Paganini; Marton Keszei; Itai Pessach; Philipp A Lang; Pietro Luigi Poliani; Silvia Giliani; Waleed Al-Herz; Morton J Cowan; Jennifer M Puck; Jack Bleesing; Tim Niehues; Catharina Schuetz; Harry Malech; Suk See DeRavin; Fabio Facchetti; Andrew R Gennery; Emma Andersson; Naynesh R Kamani; JoAnn Sekiguchi; Hamid M Alenezi; Javier Chinen; Ghassan Dbaibo; Gehad ElGhazali; Adriano Fontana; Srdjan Pasic; Cynthia Detre; Cox Terhorst; Frederick W Alt; Luigi D Notarangelo
Journal:  J Exp Med       Date:  2010-06-14       Impact factor: 14.307

9.  PRKDC mutations in a SCID patient with profound neurological abnormalities.

Authors:  Lisa Woodbine; Jessica A Neal; Nanda-Kumar Sasi; Mayuko Shimada; Karen Deem; Helen Coleman; William B Dobyns; Tomoo Ogi; Katheryn Meek; E Graham Davies; Penny A Jeggo
Journal:  J Clin Invest       Date:  2013-06-03       Impact factor: 14.808

10.  Early defects in human T-cell development severely affect distribution and maturation of thymic stromal cells: possible implications for the pathophysiology of Omenn syndrome.

Authors:  Pietro Luigi Poliani; Fabio Facchetti; Maria Ravanini; Andrew Richard Gennery; Anna Villa; Chaim M Roifman; Luigi D Notarangelo
Journal:  Blood       Date:  2009-05-04       Impact factor: 22.113

View more
  36 in total

1.  Regulating Damage from Sterile Inflammation: A Tale of Two Tolerances.

Authors:  Shin-Rong Wu; Pavan Reddy
Journal:  Trends Immunol       Date:  2017-03-03       Impact factor: 16.687

Review 2.  Tissue tolerance: a distinct concept to control acute GVHD severity.

Authors:  Shin-Rong Wu; Pavan Reddy
Journal:  Blood       Date:  2017-02-02       Impact factor: 22.113

Review 3.  Recent advances in the study of immunodeficiency and DNA damage response.

Authors:  Tomohiro Morio
Journal:  Int J Hematol       Date:  2017-05-26       Impact factor: 2.490

4.  Restoration of ATM Expression in DNA-PKcs-Deficient Cells Inhibits Signal End Joining.

Authors:  Jessica A Neal; Yao Xu; Masumi Abe; Eric Hendrickson; Katheryn Meek
Journal:  J Immunol       Date:  2016-02-26       Impact factor: 5.422

5.  Cronkhite Canada Syndrome: Significant Response to Infliximab and a Possible Clue to Pathogenesis.

Authors:  Brigid S Boland; Preet Bagi; Mark A Valasek; John T Chang; Ranier Bustamante; Lisa Madlensky; William J Sandborn; Olivier Harismendy; Samir Gupta
Journal:  Am J Gastroenterol       Date:  2016-05       Impact factor: 10.864

6.  Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences.

Authors:  Yasin Kaymaz; Cliff I Oduor; Hongbo Yu; Juliana A Otieno; John Michael Ong'echa; Ann M Moormann; Jeffrey A Bailey
Journal:  Mol Cancer Res       Date:  2017-05       Impact factor: 5.852

Review 7.  Mechanism-Based Strategies for the Management of Autoimmunity and Immune Dysregulation in Primary Immunodeficiencies.

Authors:  Jolan E Walter; Jocelyn R Farmer; Zsofia Foldvari; Troy R Torgerson; Megan A Cooper
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Nov - Dec

8.  Rubella Virus-Associated Cutaneous Granulomatous Disease: a Unique Complication in Immune-Deficient Patients, Not Limited to DNA Repair Disorders.

Authors:  David Buchbinder; Fabian Hauck; Michael H Albert; Anita Rack; Shahrzad Bakhtiar; Anna Shcherbina; Elena Deripapa; Kathleen E Sullivan; Ludmila Perelygina; Marc Eloit; Bénédicte Neven; Philippe Pérot; Despina Moshous; Félipe Suarez; Christine Bodemer; Francisco A Bonilla; Louise E Vaz; Alfons L Krol; Christoph Klein; Mikko Seppanen; Diane J Nugent; Jasjit Singh; Hans D Ochs
Journal:  J Clin Immunol       Date:  2019-01-03       Impact factor: 8.317

Review 9.  Non-homologous DNA end joining and alternative pathways to double-strand break repair.

Authors:  Howard H Y Chang; Nicholas R Pannunzio; Noritaka Adachi; Michael R Lieber
Journal:  Nat Rev Mol Cell Biol       Date:  2017-05-17       Impact factor: 94.444

Review 10.  Central tolerance to self revealed by the autoimmune regulator.

Authors:  Alice Y Chan; Mark S Anderson
Journal:  Ann N Y Acad Sci       Date:  2015-11       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.